These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26171487)

  • 61. Pharmacogenetics of antidepressant response.
    Porcelli S; Drago A; Fabbri C; Gibiino S; Calati R; Serretti A
    J Psychiatry Neurosci; 2011 Mar; 36(2):87-113. PubMed ID: 21172166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circadian rhythms and treatment implications in depression.
    Monteleone P; Martiadis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: can computational intelligence be used to augment clinical assessments?
    Athreya AP; Iyer R; Wang L; Weinshilboum RM; Bobo WV
    Pharmacogenomics; 2019 Sep; 20(14):983-988. PubMed ID: 31559920
    [No Abstract]   [Full Text] [Related]  

  • 64. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response.
    Janssen DG; Caniato RN; Verster JC; Baune BT
    Hum Psychopharmacol; 2010 Apr; 25(3):201-15. PubMed ID: 20373471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetics and pharmacogenetics of mood disorders.
    Serretti A
    Psychiatr Pol; 2017 Apr; 51(2):197-203. PubMed ID: 28581531
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The value of pharmacogenetic tests in antidepressive medication therapy].
    Kirchheiner J; Sasse J; Roots I; Brockmöller J; Bauer M
    Nervenarzt; 2005 Nov; 76(11):1340-54. PubMed ID: 15864514
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacogenomic strategy for individualizing antidepressant therapy.
    Lin KM; Perlis RH; Wan YJ
    Dialogues Clin Neurosci; 2008; 10(4):401-8. PubMed ID: 19170397
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacogenetics of antidepressant response: an update.
    Drago A; De Ronchi D; Serretti A
    Hum Genomics; 2009 Apr; 3(3):257-74. PubMed ID: 19403460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of depression pharmacogenetic decision support tools in shared decision making.
    Arandjelovic K; Eyre HA; Lenze E; Singh AB; Berk M; Bousman C
    J Neural Transm (Vienna); 2019 Jan; 126(1):87-94. PubMed ID: 29082439
    [TBL] [Abstract][Full Text] [Related]  

  • 70. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.
    Serretti A; Artioli P
    Psychopharmacology (Berl); 2004 Aug; 174(4):490-503. PubMed ID: 14997279
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic Implications of microRNAs in Depressive Disorders: A Review.
    Hassan M; Amir A; Shahzadi S; Kloczkowski A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comment on "preclinical models: status of basic research in depression".
    Overstreet DH; Daws LC; Yadid G; Friedman E; Mathé AA; Janowsky DS
    Biol Psychiatry; 2003 Feb; 53(3):268-70; author reply 270. PubMed ID: 12559663
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacogenomic testing and antidepressant response: problems and promises.
    Smith TL; Nemeroff CB
    Braz J Psychiatry; 2020 Apr; 42(2):116-117. PubMed ID: 32187320
    [No Abstract]   [Full Text] [Related]  

  • 74. Panacea, placebo or poison? Genetically guided treatment for depression.
    Nurmi EL
    Braz J Psychiatry; 2020 Apr; 42(2):118-119. PubMed ID: 32348435
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacogenetics of antidepressants.
    Crisafulli C; Fabbri C; Porcelli S; Drago A; Spina E; De Ronchi D; Serretti A
    Front Pharmacol; 2011; 2():6. PubMed ID: 21687501
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The temporo-spatial context. A neglected aspect of the depressive response.
    León CA
    Acta Psychiatr Scand; 1981 Feb; 63(2):129-46. PubMed ID: 7234471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Current state and potential of pharmacogenetic studies in the treatment of depression].
    Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
    Gardier AM
    Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
    Fabbri C; Porcelli S; Serretti A
    Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.